JP Morgan Maintains Overweight on Tenet Healthcare, Lowers Price Target to $81
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Calvin Sternick has maintained an Overweight rating on Tenet Healthcare (NYSE:THC) but has reduced the price target from $91 to $81.
November 17, 2023 | 4:11 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan has maintained an Overweight rating on Tenet Healthcare but lowered the price target from $91 to $81.
The reduction in price target by JP Morgan, despite maintaining an Overweight rating, could lead to a negative short-term sentiment among investors, potentially causing a decrease in the stock price of Tenet Healthcare.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100